Showing results (861-870 of 1,487) with videos related to

Sort By:
Pageof 149
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2003
Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseJuha-Matti Savola, Michael Hill, Mia Engstrom, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 13, 2011
Characterization of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in vitro and in the MPTP-lesioned primate: R-MDMA reduces severity of dyskinesia, whereas S-MDMA extends duration of ON-timePhilippe Huot, Tom H Johnston, Katie D Lewis, et al.
Archives of Internal Medicine|September 1, 1989
Vitamin B12 malabsorption in patients with acquired immunodeficiency syndromeG R Harriman, P D Smith, M K Horne, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 21, 2014
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKDLesley A Inker, Brad C Astor, Chester H Fox, et al.
Annals of Neurology|October 26, 2018
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving conceptsAlberto J Espay, Francesca Morgante, Aristide Merola, et al.
Respiratory Medicine|March 7, 2007
Predicting and evaluating response to omalizumab in patients with severe allergic asthmaJ Bousquet, K Rabe, M Humbert, et al.
Journal of Gerontology|March 1, 1993
Oral health status of the elderly in New EnglandC W Douglass, A M Jette, C H Fox, et al.
Journal of Community Health|August 31, 2015
Perspectives on Smoking Cessation in Northern AppalachiaElisa M Rodriguez, Annamaria Masucci Twarozek, Deborah O Erwin, et al.
Pageof 149